These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36309383)

  • 1. Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology.
    DE Felice F; Mazzoni L; Musio D; Tombolini V; Moriconi F
    In Vivo; 2022; 36(6):2986-2992. PubMed ID: 36309383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Expectation-Maximization Algorithm for Including Oncological COVID-19 Deaths in Survival Analysis.
    De Felice F; Mazzoni L; Moriconi F
    Curr Oncol; 2023 Feb; 30(2):2105-2126. PubMed ID: 36826124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden Imputations and the Kaplan-Meier Estimator.
    Cole SR; Edwards JK; Naimi AI; Muñoz A
    Am J Epidemiol; 2020 Nov; 189(11):1408-1411. PubMed ID: 32412079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating implant survival in the presence of competing risks.
    Biau DJ; Hamadouche M
    Int Orthop; 2011 Feb; 35(2):151-5. PubMed ID: 20652695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
    James ND; Sydes MR; Clarke NW; Mason MD; Dearnaley DP; Spears MR; Ritchie AW; Parker CC; Russell JM; Attard G; de Bono J; Cross W; Jones RJ; Thalmann G; Amos C; Matheson D; Millman R; Alzouebi M; Beesley S; Birtle AJ; Brock S; Cathomas R; Chakraborti P; Chowdhury S; Cook A; Elliott T; Gale J; Gibbs S; Graham JD; Hetherington J; Hughes R; Laing R; McKinna F; McLaren DB; O'Sullivan JM; Parikh O; Peedell C; Protheroe A; Robinson AJ; Srihari N; Srinivasan R; Staffurth J; Sundar S; Tolan S; Tsang D; Wagstaff J; Parmar MK;
    Lancet; 2016 Mar; 387(10024):1163-77. PubMed ID: 26719232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SurvdigitizeR: an algorithm for automated survival curve digitization.
    Zhang JZ; Rios JD; Pechlivanoglou T; Yang A; Zhang Q; Deris D; Cromwell I; Pechlivanoglou P
    BMC Med Res Methodol; 2024 Jul; 24(1):147. PubMed ID: 39003440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2024 Jan; 482(1):143-157. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: net survival and cause-specific survival rates after multiple imputation.
    Morisot A; Bessaoud F; Landais P; Rébillard X; Trétarre B; Daurès JP
    BMC Med Res Methodol; 2015 Jul; 15():54. PubMed ID: 26216355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.
    Chiba Y
    Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CondiS: A conditional survival distribution-based method for censored data imputation overcoming the hurdle in machine learning-based survival analysis.
    Wang Y; Flowers CR; Li Z; Huang X
    J Biomed Inform; 2022 Jul; 131():104117. PubMed ID: 35690348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
    Royston P; Parmar MK; Altman DG
    J Natl Cancer Inst; 2008 Jan; 100(2):92-7. PubMed ID: 18182621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail.
    Gong Q; Fang L
    Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of gastric cancer survival: using an artificial hierarchical neural network.
    Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A
    Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.
    Kountourakis P; Missitzis I; Doufexis D; Zobolas V; Pissakas G; Arnogiannaki N; Maliou S; Sotiropoulou A; Ardavanis A
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):221-8. PubMed ID: 20387073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.